Objective-The site-specificity of endothelial phenotype is attributable to the local hemodynamic forces. The flow regulation of microRNAs in endothelial cells (ECs) plays a significant role in vascular homeostasis and diseases. The objective of this study was to elucidate the molecular mechanism by which the pulsatile shear flow-induced microRNA-23b (miR-23b) exerts antiproliferative effects on ECs. Approach and Results-We used a combination of a cell perfusion system and experimental animals to examine the flow regulation of miR-23b in modulating EC proliferation. Our results demonstrated that pulsatile shear flow induces the transcription factor Krüppel-like factor 2 to promote miR-23b biosynthesis; the increase in miR-23b then represses cyclin H to impair the activity and integrity of cyclin-dependent kinase-activating kinase (CAK) complex. The inhibitory effect of miR-23b on CAK exerts dual actions to suppress cell cycle progression, and reduce basal transcription by deactivating RNA polymerase II. Whereas pulsatile shear flow regulates the miR-23b/CAK pathway to exert antiproliferative effects on ECs, oscillatory shear flow has little effect on the miR-23b/CAK pathway and hence does not cause EC growth arrest. Such flow pattern-dependent phenomena are validated with an in vivo model on rat carotid artery: the flow disturbance induced by partial carotid ligation led to a lower expression of miR-23b and a higher EC proliferation in comparison with the pulsatile flow regions of the unligated vessels. Local delivery of miR-23b mitigated the proliferative EC phenotype in partially ligated vessels. Conclusions-Our findings unveil a novel mechanism by which hemodynamic forces modulate EC proliferative phenotype through the miR-23b/CAK pathway. (Arterioscler Thromb Vasc Biol. 2014;34:1437-1445.) The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
H emodynamic forces play a pivotal role in modulating the physiological and pathological behaviors of vascular endothelial cells (ECs). 1 Pulsatile shear flow (PS), which exists in the straight part of arterial tree with a high shear stress and a clear forward direction, is associated with quiescent ECs presenting the atheroprotective phenotypes. 2 In contrast, the disturbed oscillatory shear flow (OS), which exists at vascular curvatures and bifurcations and has no clear flow direction, converts ECs toward a more active state associated with proinflammatory phenotypes with high EC turnover and atherogenic gene expressions. 3 Recent studies have demonstrated that microRNAs participate in the flow regulation of endothelial functions, 4, 5 but the feedback regulation of signaling molecules at post-transcriptional level remains to be established.
Comprehensive analyses of microRNA expression profiling in vascular ECs reveal that a series of microRNAs is differentially expressed, both in vitro and in vivo, in response to different patterns of flow. 4, 6, 7 The transcription factor, Krüppel-like factor 2 (KLF2), is a major mediator for flow regulation of EC functions 8, 9 ; overexpression of KLF2 leads to the expression of several microRNAs, including microRNA-23b (miR-23b). 10 Our previous studies demonstrated that PS upregulates KLF2, miR-23b, and miR-19a to suppress EC proliferation 4, 11, 12 and confer the atheroprotective effect of PS. Conversely, other microRNAs such as miR-21, miR-663, and miR-712 can mediate the proinflammatory response of ECs induced by OS. 5, 13, 14 Recent studies demonstrate the differential microRNA expression in different locations of the arterial tree, for example, a higher expression of miR-10a and a lower expression of miR-92a at the descending thoracic aorta with atheroprotective flow, in comparison with the internal curvature of aortic arch with athero-prone flow. 7 These studies support the important roles of microRNAs in regulating endothelial phenotypes under physiological and pathophysiological conditions. July 2014
Recent studies, including ours, have shown the important roles of miR-23b in cell growth, 4, 15, 16 angiogenesis, 17 and stem cell differentiation. 18 More than 20 putative targets of miR-23b have been reported, and these have been confirmed in a variety of contexts by the pairing of the seed sequence and mRNA 3′ untranslated regions (3′UTRs). For instance, Zhou et al 17 demonstrated the proangiogenic role of miR-23b by targeting sprouty2; Zhang et al 15 reported that miR-23b represses cancer cell proliferation and migration by regulating a cohort of prometastatic genes. We previously reported that inhibition of miR-23b reversed the PS-induced E2F1 reduction and retinoblastoma protein (Rb) hypophosphorylation and attenuated the PS-induced EC growth arrest. 4 The direct target of miR-23b that mediates these processes, however, remains unclear.
Herein, we report that the PS-induced miR-23b modulates cell cycle regulatory networks through the post-transcriptional repression of cyclin H. Importantly, cyclin H repression impairs cyclin-dependent kinase (CDK)-activating kinase (CAK) complex to deactivate CDK2, CDK4, and RNA polymerase II (Pol II), thus further attenuating the transcription of cell cycle regulators that lead to EC growth arrest. Moreover, in vivo studies performed on rat carotid arteries showed that, similar to our in vitro findings, different flow patterns differentially regulate EC proliferation through the miR-23b/CAK pathway. We thus demonstrate that miR-23b is a mechanosensitive microRNA both in vitro and in vivo. Our findings elucidate the molecular mechanism by which miR-23b modulates mechanotransduction and vascular homeostasis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

PS Induces the Expression of miR-23b Cluster Through KLF2
To explore the dynamic regulation of miR-23b, we examined the temporal expression profiles of primary (pri-miR-23b) and mature miR-23b in ECs exposed to PS over 24 hours. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses revealed that PS increased the expressions of both pri-miR-23b and miR-23b over 24 hours, with the pri-miR-23b level peaking at 12 hours ( Figure 1A ) and the mature miR-23b level being sustained over 24 hours ( Figure 1B) . A KLF2-binding motif (CACCC) was identified in the miR-23b promoter region ( Figure IA in the online-only Data Supplement), suggesting the involvement of this shearsensitive transcription factor in regulating miR-23b biosynthesis. The temporal expression profile showed that KLF2 was induced by PS within 1 hour and sustained over 24 hours ( Figure 1C ). To verify that KLF2 mediates the PS induction of miR-23b, KLF2 was knocked down with KLF2-specific small interfering RNA (siKLF2) transfection in ECs before being subjected to PS. The results showed that siKLF2 attenuated the PS-induced increases in pri-miR-23b and mature miR-23b ( Figure 1D and 1E, tested at their respective 4-and 24-hour peaks). Overexpression of KLF2 with adenovirus induced both pri-miR-23b and mature miR-23b ( Figure 1F ). Furthermore,
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3′ untranslated region the putative promoter region of miR-23b (≈700 bp flanking sequence upstream of miR-23b precursor) containing a KLF2binding motif, as suggested by Yeung et al, 19 was subcloned into pGL2 luciferase reporter vector (Pro23b) for promoter activity assay. Overexpression of KLF2 increased the luciferase activity of the Pro23b construct. Mutation of KLF2-binding motif (Pro23bmt) blocked the KLF2-dependent activation ( Figure  IB in the online-only Data Supplement). Taken together, these findings strongly indicate that KLF2 is a direct upstream transcription factor for PS induction of miR-23b in ECs.
PS-Induced miR-23b Modulates the Expressions and Activities of Cell Cycle Regulatory Proteins as Well as Cell Cycle Progression
To examine the temporal effect of PS on EC proliferation, we performed the bromodeoxyuridine (BrdU) incorporation assay with ECs subjected to various durations of PS. As shown in Figure Figure 2A ). Transfection of AM23b partially reversed the PS suppressions of P-Rb, cyclin E, P-CDK2, P-CDK4, CDK2, and CDK4 ( Figure 2B ), which may in turn promote EC entry into the synthetic phase of cell cycle. The effect of AM23b on expression levels of CDK2 and CDK4, but not cyclin E, was confirmed at the mRNA level with qRT-PCR; AM23b had no significant effects on other cell cycle regulators (cyclin A, cyclin D1, CDK1, and p27; Figure 2C ). However, based on the microRNA target prediction, 20 neither CDK2 nor CDK4 mRNAs contain miR-23b-binding sequence in their 3′UTRs. Because AM23b transfection attenuated the PS reductions of CDK2 and CDK4 activities, we examined the miR-23b targets among the upstream regulators of CDK2 and CDK4 and found the miR-23b-binding sequence in the 3′UTR of cyclin H mRNA, which is highly conserved among human, chimpanzee, mouse, rat, and dog ( Figure III in the onlineonly Data Supplement). Cyclin H has been demonstrated to form the CAK with CDK7 to phosphorylate CDK1, CDK2, and CDK4. 21 We found that PS indeed downregulated cyclin H and that transfecting ECs with AM23b attenuated the PS downregulation of cyclin H, but did not have significant effects on CDK7 ( Figure 2D and 2E). These results indicate that cyclin H may play a role in the miR-23b-mediated reductions of expressions and activities of CDK2 and CDK4 and hence the cell cycle progression under PS.
Cyclin H Is a Direct Target of miR-23b in Regulating EC Proliferation Under PS
To determine whether cyclin H is a direct target of miR-23b in ECs, we constructed reporters containing the luciferase complementary DNA fused to either the wild-type or mutant 3′UTR of cyclin H mRNA ( Figure 3A ; cyclin H-3′UTR-wt and cyclin H-3′UTR-mt, respectively) and tested their activities in ECs. Transfection of pre-miR-23b (PM23b) repressed the luciferase activity of cyclin H-3′UTR-wt; the repression was not observed with empty vector or cyclin H-3′UTR-mt ( Figure 3B ). In comparison with the static control condition, PS reduced the reporter activity of cyclin H-3′UTR-wt, but did not have significant effect on the mutant ( Figure 3C ). To verify the association of miR-23b and cyclin H mRNA in the microRNA-induced silencing complex (miRISC), we performed RNA immunoprecipitation, 22 using the anti-panargonaute antibody. The miR-23b and cyclin H transcripts in miRISC were found to increase under PS in comparison with static control ( Figure 3D ). These results indicate that PS induced the association of cyclin H and miR-23b in miRISC and that the cyclin H modulation by PS involves a microRNAdependent mechanism. In addition, overexpression of miR-23b with PM23b in ECs decreased cyclin H expression (at both protein and mRNA levels, as shown in Figure 3E 
PS-Induced miR-23b Suppresses Basal Transcription by Targeting CAK
The CAK complex (cyclin H-CDK7) regulates basal transcription by phosphorylating the C-terminal domain (CTD) of Pol II, 23 in addition to regulating the activities of CDKs. The CTD consists of 52 repeats of the highly conserved sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser, and the Ser residues at positions 2 and 5 are known targets for CAK phosphorylation. Western blot analyses showed that the CTD was highly phosphorylated at Ser5 in ECs kept under static control condition for 24 hours, and that prolonged PS (12 and 24 hours) led to dephosphorylation at Ser5 below the static control level ( Figure 4A ). Interestingly, in contrast to Ser5, the phosphorylation level of Ser2 was low in static ECs at 24 hours; after showing transient increases at 1 and 4 hours under PS, the Ser2 phosphorylation decreased to the low static control level. These results indicate that the reduction of phosphorylation of Ser5, rather than Ser2, is a consequence of prolonged PS. Together with the results that the prolonged PS decreased expression levels of cyclin H/CDK7 (Figures 2E, 2F , and 4A), these findings indicate that PS downregulates the CAK pathway to modulate Pol II activities. To further confirm the effect of PS on the CTD phosphorylation, we performed immunofluorescence staining with the antibody recognizing the Ser5 phosphorylation, and the results agreed with Western blot analyses ( Figure V in the online-only Data Supplement).
To investigate whether miR-23b mediates the PS regulation of CAK activity and the CTD phosphorylation, ECs were transfected with either AM23b or AM-Ctrl and then subjected to 24-hour PS or kept as static control. As shown in Figure 4B , AM23b transfection reversed the PS-induced Ser5 dephosphorylation, but not Ser2 phosphorylation nor the level of Pol II. In ECs under PS, AM23b transfection also restored the integrity and activity of the CAK complex as indicated by the increased presence of CDK7 in the immunocomplex with cyclin H and the increases of GST-CTD phosphorylation, respectively ( Figure 4C ). Immunostaining ( Figure 4D ) also showed that AM23b transfection increased Ser5 phosphorylation of the CTD in EC nuclei under PS. Furthermore, our results revealed that overexpression of cyclin H reversed the PS suppression of CTD phosphorylation, and that knocking down cyclin H decreased the CTD phosphorylation ( Figure  VI in the online-only Data Supplement). Taken together, these data indicate that miR-23b mediated the PS-induced downregulation of cyclin H expression and hence the decrease in CAK activity, which in turn reduced Ser5 phosphorylation of the CTD. To examine the effects of altered CTD phosphorylation on transcription controls of the cell cycle regulatory proteins (CDK1, CDK2, and CDK4), chromatin immunoprecipitation assays were performed using antibodies against Ser5 phosphorylation of the CTD and total Pol II. The immunocomplexes were analyzed using qRT-PCR with primers specific to the proximal regions of the transcription start sites (TSS) of CDK1, CDK2, and CDK4. PS significantly decreased both the phospho-CTD (Ser5) and total Pol II occupancy in the TSS of these genes ( Figure 4E and 4F) , consistent with the PS reductions of CTD phosphorylation and Pol II expression. As expected, AM23b transfection attenuated the reductions of phospho-CTD occupancy in the TSS of these genes, but had no significant effects on the total Pol II binding; these findings are consistent with the findings that miR-23b is involved in Ser5 phosphorylation of the CTD but not Pol II expression ( Figure 4B ). Notably, although AM23b enhanced the phospho-CTD binding at CDK1 TSS ( Figure 4E ), its mRNA level was not affected (Figure 2E ), indicating that the increase of initiation complex at TSS may not be sufficient to progress through the subsequent transcription events.
Differential Regulation of miR-23b by Flow Patterns
PS and OS differentially regulate EC gene expression and functions. As shown in Figure 5A , PS significantly increased KLF2 and miR-23b expressions in comparison with the levels under OS and static conditions. The fluorescence in situ hybridization with miR-23b-locked nucleic acid probe showed that miR-23b staining in the nuclear and perinuclear regions was much stronger under PS than OS ( Figure VII in the online-only Data Supplement), which is consistent with the qRT-PCR results ( Figure 5A ). Furthermore, in comparison with PS, Ser5 phosphorylation of the CTD and expressions of CAK components were significantly higher under static and OS conditions ( Figure 5B ). Under static control and OS conditions, overexpression of miR-23b with PM23b decreased the cyclin H expression and CAK complexes to levels similar to those under PS ( Figure 5B ). Along the same line, the number of BrdU-positive cells under OS was significantly reduced, and that miR-23b overexpression significantly attenuated the EC proliferation under OS ( Figure 5C ). These findings indicate that PS but not OS exerts strong antiproliferative effect on ECs through the miR-23b/CAK pathway ( Figure 5D ).
Flow Disturbance Reduces miR-23b Expression and Promotes EC Proliferation in Partial Carotid Ligation In Vivo
To validate our in vitro findings, the flow regulation of miR-23b and EC proliferation was studied in the rat carotid partial ligation model. 24 Three branches of the left carotid artery (LCA) were surgically ligated (partial ligation, PL) or left intact (sham). Ultrasonographic study confirmed that the partial carotid ligation created a disturbed flow with low shear stress in PL, whereas the flow in the sham group was maintained as pulsatile flow with high shear stress ( Figure VIII in the online-only Data Supplement). The effects of blood flow disturbance on the expression levels of miR-23b were examined 1 week postoperation. Intima RNA was extracted from the segments of LCAs by perfusion with TRIzol and subjected to qRT-PCR analyses. In agreement with our in vitro studies, the expressions of KLF2 and miR-23b in PL were significantly lower than those in sham, and the levels of cyclin H and proliferation marker Ki67 in PL were higher than those in sham ( Figure 6A ). Western blot analyses of intima proteins extracted from LCAs showed that Ser5 phosphorylation of the CTD and the expression of cyclin H were higher in PL than in sham ( Figure 6B ). Furthermore, the immunofluorescence staining of the cross-sections of LCA segments revealed that the PL group had a reduced level of miR-23b ( Figure 6C ) and a strong proliferative phenotype ( Figure 6D ) in endothelium (as indicated by detection of Von Willebrand factor-positive and CD45-negative cells in Figure IX in the online-only Data Supplement) in comparison with sham group. To further determine the effect of miR-23b on EC proliferative phenotype in response to flow disturbance, we locally introduced miR-23b into the segments of LCAs with PM23b-loaded pluronic F127 thermogel immediately after partial ligation of LCAs. As shown in Figure 6E to 6H, local delivery of PM23b attenuated PL inductions of cyclin H, Ki67, as well as Ser5 phosphorylation of the CTD, in comparison with those of PL receiving control RNA. These outcomes are consistent with our in vitro results and strongly support that miR-23b is critical in regulating endothelial proliferation in response to flow disturbance. 
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Discussion
miR-23b has been shown to play important roles in tumor and cardiovascular biology. Recent studies demonstrated that miR-23b is downregulated in various tumor types when compared with the normal tissues and that it functions as a tumor suppressor to repress malignant growth of the cell lines tested. 15, 16, 25 Our previous report 4 and present findings also support the antiproliferative role of miR-23b in vascular ECs responding to hemodynamic force with a clear direction. As summarized in Figure 5D , we have demonstrated a novel mechanism by which flow patterns modulate EC phenotypes through miR-23b. Our data suggest that PS induction of miR-23b is dependent on flow-sensitive transcription factor KLF2. The KLF2-dependent elevation of miR-23b in response to PS leads to the decrease of cyclin H, which impairs the integrity and activity of the CAK complex to lead to dual actions: the reductions of CDK2 and CDK4 activities, and the attenuation of CTD phosphorylation of Pol II, which reduces CDK2/4 transcription. These actions result in Rb hypophosphorylation and hence the antiproliferative/quiescent EC phenotype under prolonged PS. Our findings also demonstrate that exposure of ECs to disturbed flow leads to downregulation of miR-23b and the augment of CAK pathway and proliferative phenotype and that overexpression of miR-23b attenuated these effects caused by disturbed flow, both in vitro and in vivo. These findings establish the roles of a flow-sensitive microRNA in regulating endothelial phenotypes and vascular pathophysiology involving local hemodynamics.
KLF2 has been shown as an atheroprotective transcription factor in ECs that modulates ≈70% of the genes that are responsive to shear stress. 8 The flow induction of KLF2 is believed to regulate many endothelial functions, including EC proliferation. 8, 9 Indeed, our results demonstrate that KLF2 overexpression is sufficient to reduce the BrdU incorporation of ECs, and that knocking down KLF2 significantly increases the percentage of BrdU-positive ECs under both static control and PS conditions, in comparison with control transfection ( Figure X in the online-only Data Supplement). However, there was a lack of a clear understanding of the mechanism that mediates this antiproliferative effect of KLF2 on ECs. Recent studies reported that KLF2 itself is regulated at the post-transcriptional level 26 and that endothelial overexpression of KLF2 induces the expression and secretion of microR-NAs. 10 Our data demonstrate that KLF2 overexpression leads to inductions of primary and mature miR-23b and that knocking down KLF2 blocks the PS induction of miR-23b. Thus, our present findings provide a consistent line of evidence that not only confirms the antiproliferative role of KLF2 but also identifies miR-23b as a novel modulator for KLF2-regualted EC phenotype.
We further examined the molecular mechanism by which miR-23b modulates cell cycle regulatory proteins. Although miR-23b mediates PS suppressions of CDK2 and CDK4 expression and phosphorylation, the lack of miR-23b-binding site in the 3′UTR of these CDKs suggests that the miR-23b regulation of these proteins is not through direct targeting. We have identified cyclin H in the CAK complex as a direct target for miR-23b (Figure 3) ; the CAK complex possesses the dual capabilities of modulating basal transcription and phosphorylating the T loop of CDKs that controls cell cycle progression. 27 In addition to CDK2/4 phosphorylation, CAK activity is known to modulate the initiation event of transcription through phosphorylating the Ser5 residues of the CTD of Pol II ( Figure XI in the online-only Data Supplement). A recent study has demonstrated that 6-hour laminar shear increases Ser2 but not Ser5 phosphorylation of the CTD and its recruitment to eNOS gene. 28 In agreement with this finding, our present study shows that short-term PS (1 and 4 hours) increases the CTD phosphorylation at Ser2 but not Ser5, whereas prolonged PS (12 and 24 hours) causes a reduction in the phosphorylation of both Ser2 and Ser5. The temporal changes of CTD phosphorylation are in agreement with the downregulation of CAK components in ECs under PS. Along the same line, overexpression of KLF2 mimicking PS condition led to the decreases of Ser5 phosphorylation of the CTD and cyclin H expression ( Figure XII in the online-only Data Supplement). Most importantly, AM23b restores Ser5 phosphorylation of the CTD and its recruitment to the TSS of CDK2 and CDK4, validating that PS regulation of CAK activity is mediated by miR-23b. In this respect, the PS-induced miR-23b exerts the antiproliferative effects on ECs through both inactivation and transcriptional suppression of cell cycle regulatory proteins.
Studies with culture ECs in flow chamber have shown that laminar flow with high shear stress causes ECs to be in a quiescent state, whereas disturbed flow patterns increase EC turnover. [29] [30] [31] In agreement with these observations, our results have shown that BrdU incorporation in ECs is significantly less under PS than OS. Our in vitro findings indicate that PS and OS cause differential effects on miR-23b expression, which acts through CAK pathway to cause opposite changes in EC proliferation in response to these 2 flow patterns. These results reflect the in vivo conditions that ECs in the arterial tree exposed to PS are primarily quiescent, and that the increase of EC turnover is usually associated with athero-prone sites where the blood flow is disturbed. 3 The disturbed flow created by partial carotid ligation has been reported to cause carotid intima-media thickening 32 and advanced lesion development. 33 Using this partial ligation model, we have shown the differential effects of pulsatile flow versus disturbed flow on the expression levels of miR-23b and cyclin H, as well as EC proliferation, in rat carotid arteries. Thus, in comparison with sham with high shear stress, the ECs in PL exposed to low and oscillatory shear stress have lower miR-23b expression and higher cyclin H expression, CTD phosphorylation, and EC proliferation. Furthermore, our study demonstrates the therapeutic role of miR-23b by showing that the pathological effects (eg, CAK activation and EC proliferative phenotype) after partial carotid ligation can be suppressed by local delivery of miR-23b. These findings validate the significance of the miR-23b→CAK/Pol II→cell proliferation pathway in regulating vascular functions in vivo.
In summary, we used in vitro cell perfusion systems and an in vivo partial carotid ligation animal model to demonstrate the functional role of miR-23b in effecting antiproliferative actions by modulation of cell cycle regulatory proteins and inhibition of basal transcription. Our findings also implicate the flow-sensitive miR-23b as a potential therapeutic target for maintaining EC homeostasis.
